US20170042952A1 - Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process - Google Patents

Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process Download PDF

Info

Publication number
US20170042952A1
US20170042952A1 US15/334,346 US201615334346A US2017042952A1 US 20170042952 A1 US20170042952 A1 US 20170042952A1 US 201615334346 A US201615334346 A US 201615334346A US 2017042952 A1 US2017042952 A1 US 2017042952A1
Authority
US
United States
Prior art keywords
extracts
ginkgo
water
solution
pesticides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/334,346
Inventor
Andrea Giori
Giacomo Mombelli
Sabrina Arpini
Mario Acerbi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41786232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20170042952(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena SpA filed Critical Indena SpA
Priority to US15/334,346 priority Critical patent/US20170042952A1/en
Assigned to INDENA S.P.A. reassignment INDENA S.P.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACERBI, MARIO, ARPINI, SABRINA, GIORI, ANDREA, MOMBELLI, GIACOMO
Publication of US20170042952A1 publication Critical patent/US20170042952A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/23Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/04Solvent extraction of solutions which are liquid
    • B01D11/0492Applications, solvents used
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/35Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Definitions

  • the present invention relates to a process for removing pesticides from Ginkgo biloba extracts, and the extracts obtainable by said process.
  • Ginkgo biloba leaf extracts have long been used in Chinese traditional medicine and in numerous Western countries due to the multiple pharmacological properties attributed to the components of said extracts (vasodilating, immuno stimulating, antioxidant and antiaggregant properties).
  • U.S. Pat. No. 5,660,832 discloses a general process for purifying plant extracts of pesticides, comprising extraction with a polar solvent in a specific pH range, followed by absorption and deabsorption on resins. In the case of Ginkgo biloba leaves, the extraction is performed with a mixture of ethanol and water.
  • Pesticides are not the only undesirable contaminants in Ginkgo biloba extracts: for example, EP 1 968 625 describes a multi-step preparation method of a Ginkgo biloba extract with a low content of 4′-O-methyl pyridoxine, also known as ginkgo toxin, and/or biflavones. In this case, however, the undesirable components are naturally present in the plant.
  • EP 1 868 626 discloses a method of preparing Ginkgo biloba extracts having a low content of polycyclic aromatic hydrocarbons deriving from the use of fossil fuels close to Ginkgo crops.
  • the process described is highly complex, comprising eleven steps, long preparation times and the use of expensive reagents such as polyamides, or toxic reagents such as lead salts.
  • the process of the invention in addition to eliminating or substantially reducing the residual pesticide content, also allows the content of ginkgo terpenes and their relative ratio to be controlled.
  • the invention therefore also relates to extracts obtainable from the process described above, with a pre-determined ratio of ginkgo terpenes.
  • step a) produces one fraction enriched with ginkgo terpenes and one enriched with ginkgo flavone glycosides by extraction with a water-immiscible solvent selected from esters, chlorinated hydrocarbons, mixtures of hydrocarbons and alcohols, ketones and mixtures of ketones and alcohols, preferably a C2-C8 ester, such as ethyl acetate and t-butyl acetate or a toluene-butanol mixture.
  • a water-immiscible solvent selected from esters, chlorinated hydrocarbons, mixtures of hydrocarbons and alcohols, ketones and mixtures of ketones and alcohols, preferably a C2-C8 ester, such as ethyl acetate and t-butyl acetate or a toluene-butanol mixture.
  • the ginkgo terpenes are crystallised in water and C1-C5 alcohol mixtures, while the crystallisation from the terpene-rich fraction obtained at step c) is performed in water or a mixture of water and C1-C3 alcohols.
  • the process according to the invention eliminates medium-polarity pesticides which are not removed with the ginkgols.
  • the resulting solution is reflux heated under stirring, then cooled to room temperature and left to crystallise for 4 days.
  • the aqueous solution is concentrated to a volume of 0.3 l; 0.1 l of 95° EtOH is then added, and the solution is heated to 50° C. under stirring, then cooled to room temperature and left to crystallise for 3 days.
  • the resulting solution is reflux heated under stirring for 45 minutes, then cooled to room temperature and left to crystallise for 3-4 days.
  • the concentrate is taken up with water to obtain a solution with approx. 10% of dry residue.
  • the resulting solution is reflux heated under stirring for 25 minutes, then cooled to room temperature and left to crystallise for 2 days.
  • the suspension obtained is filtered.
  • the water-ethanol solution is concentrated under vacuum to a small volume, substituting with water.
  • the concentrate is taken up with 20% ethanol to obtain a solution with a dry residue of 20%.
  • the resulting solution is reflux heated under stirring for 30 minutes, then cooled to room temperature and left to crystallise for 5 days.
  • the resulting solution is reflux heated under stirring for 1 hour, then cooled to room temperature and left to crystallise for 2 days.
  • the process described removes the pesticides and allows the terpene content of the Ginkgo biloba extracts to be controlled, adjusting it as required at the step when the purified intermediates are mixed.
  • the 24/6 ratio (GFG/GT) considered ideal in the extracts often differs from the natural ratio encountered in the plants.
  • Chinese leaves often have a higher terpene content, and a ginkgo terpene titre reduction step is required to obtain conforming extracts.
  • the table below shows the pesticide contents of extracts obtained according to the procedures described above. Two tests were conducted for each example: the procedure disclosed in the patent was exactly followed in the first, and treatment of the terpene fraction was added in the second.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Process for removing pesticides from Ginkgo biloba extracts, which involves submitting an extract obtained by conventional methods to the following steps:
    • a. Liquid-liquid extraction of the extract to obtain a medium polarity fraction containing ginkgo terpenes and pesticides not removable with hexane, and a high polarity fraction containing ginkgo flavone glycosides;
    • b. crystallisation from the medium polarity fraction obtained at step a) to give an intermediate with a ginkgolide content of not less than 50%;
    • c. crystallisation from the residual solution obtained at step b) to give an intermediate with a bilobalide content of not less than 50%;
    • d. mixing of the high polarity fraction obtained at step a) with the ginkgo terpene intermediate and the bilobalide intermediate obtained at steps b) and c).

Description

  • This U.S. non-provisional application is a continuation of U.S. application Ser. No. 13/258,715 filed on Nov. 18, 2011, which is a national stage of PCT/EP2010/002046 filed on Mar. 31, 2010 which claims priority to and the benefit of Italian Application No. MI2009A000548 filed on Apr. 6, 2009, the content of which are all incorporated herein by reference in their entireties.
  • The present invention relates to a process for removing pesticides from Ginkgo biloba extracts, and the extracts obtainable by said process.
  • PRIOR ART
  • Ginkgo biloba leaf extracts have long been used in Chinese traditional medicine and in numerous Western countries due to the multiple pharmacological properties attributed to the components of said extracts (vasodilating, immuno stimulating, antioxidant and antiaggregant properties).
  • Processes for the preparation of Ginkgo biloba leaf extracts are disclosed in U.S. Pat. No. 5,700,468, EP 360 556, EP 431 535 and JP 09110713. Pesticides such as organophosphates, the toxicity of which is well documented, have been employed in the cultivation of the plants used to produce said extracts, especially in the past. Although many health and agricultural authorities have banned or restricted the use of such pesticides, it is not always easy to establish the origin of plant material, and even in countries where the use of pesticides is regulated, it is impossible to rule out unlawful or improper use of substances with pesticidal action, whose presence in the pharmaceutical or nutritional grade extract is wholly undesirable. A particularly insidious problem is possible cross-contamination from pesticides originating from nearby crops.
  • The problem of contamination in general is discussed in the Journal of AOAC International, Vol. 88(3), 2005, 729-735, which also describes a method for the determination of the organophosphate pesticide content of Ginkgo leaves by gas chromatography.
  • U.S. Pat. No. 5,660,832 discloses a general process for purifying plant extracts of pesticides, comprising extraction with a polar solvent in a specific pH range, followed by absorption and deabsorption on resins. In the case of Ginkgo biloba leaves, the extraction is performed with a mixture of ethanol and water.
  • Pesticides are not the only undesirable contaminants in Ginkgo biloba extracts: for example, EP 1 968 625 describes a multi-step preparation method of a Ginkgo biloba extract with a low content of 4′-O-methyl pyridoxine, also known as ginkgo toxin, and/or biflavones. In this case, however, the undesirable components are naturally present in the plant.
  • Finally, EP 1 868 626 discloses a method of preparing Ginkgo biloba extracts having a low content of polycyclic aromatic hydrocarbons deriving from the use of fossil fuels close to Ginkgo crops. The process described is highly complex, comprising eleven steps, long preparation times and the use of expensive reagents such as polyamides, or toxic reagents such as lead salts.
  • Practically all the known processes involve one or more steps of removal of the lipophilic components of the Ginkgo extract (in particular biflavones and ginkgols). Said extraction also reduces any lyophilic pesticide content present, while pesticides with higher polarity remain in the extract, as their behaviour is more similar to that of the hydrophilic components (such as flavone glycosides and terpenes).
  • There is consequently a need for a convenient purification method which reduces or eliminates pesticides or other pollutants from Ginkgo biloba leaf extracts in order to comply with the limits imposed by the legislation, especially in the USA, governing the residual content of any type of pesticide in products of plant origin for pharmaceutical, nutritional or cosmetic use.
  • DESCRIPTION OF THE INVENTION
  • It has now been found that the pesticide content of Ginkgo biloba extracts can be reduced by a process comprising:
      • a) liquid-liquid extraction of the extract to obtain a medium polarity fraction containing ginkgo terpenes and pesticides not removable with hexane, and a high polarity fraction containing ginkgo flavone glycosides;
      • b) crystallisation from the medium polarity fraction obtained at step a) to give an intermediate with a ginkgolide content of not less than 50%;
      • c) crystallisation from the residual solution obtained at step b) to give an intermediate with a bilobalide content of not less than 50%;
      • d) mixing of the high polarity fraction obtained at step a) with the ginkgo terpene intermediate and bilobalide intermediate obtained at steps b) and c).
  • The process of the invention, in addition to eliminating or substantially reducing the residual pesticide content, also allows the content of ginkgo terpenes and their relative ratio to be controlled.
  • The invention therefore also relates to extracts obtainable from the process described above, with a pre-determined ratio of ginkgo terpenes.
  • According to the invention, step a) produces one fraction enriched with ginkgo terpenes and one enriched with ginkgo flavone glycosides by extraction with a water-immiscible solvent selected from esters, chlorinated hydrocarbons, mixtures of hydrocarbons and alcohols, ketones and mixtures of ketones and alcohols, preferably a C2-C8 ester, such as ethyl acetate and t-butyl acetate or a toluene-butanol mixture.
  • The ginkgo terpenes are crystallised in water and C1-C5 alcohol mixtures, while the crystallisation from the terpene-rich fraction obtained at step c) is performed in water or a mixture of water and C1-C3 alcohols. □ The process according to the invention eliminates medium-polarity pesticides which are not removed with the ginkgols.
  • The invention is illustrated in greater detail in the examples below.
  • Example 1 Purification of the Extract Produced According to Example I in U.S. Pat. No. 5,700,468 and EP 0 360 556 (Indena)
  • 1) 100 kg of chopped leaves is extracted 4 times with 400 l of 60% (w/w) acetone at a temperature of approx. 50° C.
  • 2) The combined percolates are extracted in countercurrent with 500 l of hexane.
  • 3) The defatted solution is concentrated under vacuum to a volume of 200 l, left overnight at 2° C., and then centrifuged to separate the biflavone fraction.
  • 4) The aqueous solution is extracted in countercurrent with 400 l of an 8/2 v/v mixture of n-butanol/toluene.
  • 5) The organic solution is concentrated under vacuum to a small volume, substituting with water. The concentrate is taken up with water to obtain a solution with approx. 30% of dry residue.
  • 6) The solution is extracted in countercurrent with approx. 65 l of ethyl acetate. The aqueous phase is concentrated to a syrup-like consistency and dried under vacuum, to obtain an intermediate enriched with ginkgo flavone glycosides and devoid of terpenes (1.95 kg).
  • 7) The ethyl acetic phase is concentrated under vacuum to a syrup-like consistency, and the residue is taken up with 3 l of 75% aqueous ethanol.
  • 8) The solution is extracted in countercurrent with 20 l of hexane, eliminating the combined organic phases.
  • 9) The water-alcohol solution is concentrated under vacuum to a syrup-like consistency, and 0.9 l of 50% aqueous ethanol is added.
  • The resulting solution is reflux heated under stirring, then cooled to room temperature and left to crystallise for 4 days.
  • 10) The solution is then filtered and the solid washed with 50% EtOH and dried under vacuum, to obtain 95 g of purified ginkgolides.
  • 11) The mother liquor is concentrated under vacuum to eliminate the ethanol, and the residue is then taken up with 1.9 l of water and heated to 90° C. under stirring for 30 minutes. The aqueous solution is separated, and the residue is taken up 3 more times with 1.9 l of water at 90° C., the aqueous solution being recovered every time.
  • 12) The aqueous solutions are combined and extracted in countercurrent with 14 l of hexane.
  • 13) The aqueous solution is concentrated to a volume of 0.3 l; 0.1 l of 95° EtOH is then added, and the solution is heated to 50° C. under stirring, then cooled to room temperature and left to crystallise for 3 days.
  • 14) The solution is filtered and the solid is washed with 20% EtOH and dried under vacuum to obtain 103 g of purified bilobalide.
  • 15) The products obtained in points 6, 10 and 14 are mixed to give 2.15 kg of Ginkgo biloba extract with the following characteristics: ginkgo flavone glycosides 26.0%; bilobalide 3.2%; ginkgolides 3.5%; ginkgolic acids<5.0 ppm; each pesticide<10 ppb.
  • Example 2 Purification of the Extract Produced as Described in Example II of U.S. Pat. No. 5,700,468, EP 0 360 556 (Indena)
  • 1) 100 kg of chopped leaves is extracted 4 times with 400 l of 50% (w/w) methanol at the temperature of approx. 35° C.
  • 2) The combined percolates are concentrated to 100 l under vacuum at 40° C., the concentrate is taken up with 100 l of methanol, and the suspension obtained is filtered.
  • 3) The filtered solution is extracted 3 times with 100 l of a 9:2 mixture of toluene/n-butanol.
  • 4) The combined organic phases are counterwashed with 50 l of 50% methanol.
  • 5) The water-methanol solutions are concentrated under vacuum to an aqueous solution and, after filtration, are extracted with an 8:2 mixture of n-butanol/toluene.
  • 6) The organic solution is counterwashed with water and concentrated under vacuum to a small volume, substituting with water. The solution is taken up with water to obtain a solution with a dry residue of 20%.
  • 7) The resulting solution is extracted in countercurrent with 90 l of a 1:1 mixture of n-butanol/toluene. The aqueous phase is concentrated to a syrup-like consistency and dried under vacuum to obtain an intermediate enriched with ginkgo flavone glycosides and devoid of terpenes (2.05 kg).
  • 8) The n-butanol/toluene mixture is concentrated under vacuum to a syrup-like consistency, and the residue is taken up with 3.5 l of 60% aqueous ethanol.
  • 9) The resulting solution is extracted in countercurrent with 20 l of hexane, eliminating the combined organic phases.
  • 10) The water-alcohol solution is concentrated under vacuum to a syrup-like consistency, and 1.2 l of 40% aqueous ethanol is added.
  • The resulting solution is reflux heated under stirring for 45 minutes, then cooled to room temperature and left to crystallise for 3-4 days.
  • 11) The solution is then filtered and the solid washed with 40% EtOH and dried under vacuum, to obtain 97 g of purified ginkgolides.
  • 12) The mother liquor is concentrated under vacuum to eliminate the ethanol, and the residue is then taken up with 2 l of water and heated at 90° C. under stirring for 30 minutes. The aqueous solution is separated, and the residue is taken up 3 more times with 2 l of water at 90° C., the aqueous solution being recovered every time.
  • 13) The aqueous solutions are combined and extracted in countercurrent with 17 l of hexane.
  • 14) The aqueous solutions are concentrated to a volume of 0.41, and 0.15 l of 95° EtOH is added; the resulting solution is heated at 50-55° C. under stirring for 30 minutes, then cooled to room temperature and left to crystallise for 3-4 days.
  • 15) The solution is filtered and the solid is washed with 20% EtOH and dried under vacuum at 60° C. to obtain 110 g of purified bilobalide.
  • 16) The products obtained in points 7, 11 and 15 are mixed to give 2.26 kg of Ginkgo biloba extract similar to that obtained in example 1.
  • Example 3 Purification of the Extract Produced According to Example I in EP 431 535 (Schwabe)
  • 1) 100 kg of chopped leaves is extracted twice with 750 kg of 60% (w/w) acetone for 30 mins at the temperature of 57-59° C.
  • 2) The combined extracts are concentrated to an aqueous solution with a dry residue of 30-40%, an equal volume of water is added, and the mixture is left under stirring for one hour at 12° C.
  • 3) The alkylphenol-rich precipitate is separated by centrifugation and eliminated.
  • 4) 30% of ammonium sulphate is added to the clarified solution under stirring, and the solution is extracted twice with half a volume of a 6:4 mixture of methyl ethyl ketone/acetone.
  • 5) The combined methyl ethyl ketone/acetone solutions are concentrated under vacuum to a dry residue of 50-70%, and then diluted with water and 95% ethanol to obtain a 50% ethanol solution with a dry residue of 10%.
  • 6) An aqueous solution of lead hydroxide acetate is added under stirring until the colour changes from brown to light brown. The precipitate obtained is eliminated by centrifugation.
  • 7) The centrifuged solution is extracted 3 times with 1/3 volume of hexane.
  • 8) The defatted solution is concentrated to an aqueous solution under vacuum, and 20% of ammonium sulphate is added and extracted twice with half a volume of a 6:4 mixture of methyl ethyl ketone/ethanol. The combined organic phases are washed with 20% of ammonium sulphate, removing any water and solid formed.
  • 9) The clear solution is then concentrated under vacuum to a small volume, substituting with water.
  • The concentrate is taken up with water to obtain a solution with approx. 10% of dry residue.
  • 10) The solution is extracted in countercurrent with approx. 100 l of t-butyl acetate. The aqueous phase is concentrated to a syrup-like consistency and dried under vacuum to obtain an intermediate enriched with ginkgo flavone glycosides and devoid of terpenes (1.88 kg).
  • 11) The butyl acetic phase is concentrated under vacuum to a syrup-like consistency, and 0.8 l of 60% aqueous ethanol is added.
  • The resulting solution is reflux heated under stirring for 25 minutes, then cooled to room temperature and left to crystallise for 2 days.
  • 12) The solution is then filtered and the solid washed with 60% EtOH and dried under vacuum, to obtain 98 g of purified ginkgolides.
  • 13) The mother liquor is concentrated under vacuum to eliminate the ethanol, and the residue is then taken up with 1.9 l of water and heated at 90° C. under stirring for 30 minutes. The aqueous solution is separated, and the residue is taken up 3 more times with 1.9 l of water at 90° C., the aqueous solution being recovered every time.
  • 14) The combined aqueous solutions are concentrated to a volume of 0.6 l and heated to 70° C., under stirring, for 60 minutes, then cooled to room temperature and left to crystallise for 1 day.
  • 15) The resulting solution is filtered and the solid is washed with water and dried under vacuum to obtain 99 g of purified bilobalide.
  • 16) The products obtained in points 10, 12 and 15 are mixed to give 2.08 kg of Ginkgo biloba extract similar to that obtained in example 1.
  • Example 4 Purification of Extract Produced According to JP 09110713 (Nippon Green Wave)
  • 1) 100 kg of chopped ginkgo leaves is extracted 3 times with 500 l of 70% ethanol at 50° C. for 30 hours.
  • 2) The combined percolates are concentrated to 100 l under vacuum and the concentrate is taken up with 100 l of water.
  • The suspension obtained is filtered.
  • 3) The filtered solution is introduced into a chromatography column containing 100 l of HP20 resin (Mitsubishi) to adsorb the extract. The column is then washed with 200 l of water, and the extract is recovered by eluting with 200 l of 70% ethanol.
  • 4) The water-ethanol solution is concentrated under vacuum to a small volume, substituting with water. The concentrate is taken up with 20% ethanol to obtain a solution with a dry residue of 20%.
  • 5) The resulting solution is extracted in countercurrent with 70 l of methylene chloride. The water-ethanol phase is concentrated to a syrup-like consistency and dried under vacuum to obtain an intermediate enriched with ginkgo flavone glycosides and devoid of terpenes (2.4 kg).
  • 6) The chloromethylene phase is concentrated under vacuum to a syrup-like consistency, and the residue is taken up with 4 l of 75% aqueous methanol.
  • 7) The resulting solution is extracted 10 times with 2 l of hexane, eliminating the combined hexane phases.
  • 8) The water-alcohol solution is concentrated under vacuum to a syrup-like consistency, and 11 of 50% aqueous methanol is added.
  • The resulting solution is reflux heated under stirring for 30 minutes, then cooled to room temperature and left to crystallise for 5 days.
  • 9) The solution is then filtered and the solid washed with 50% MeOH and dried under vacuum, to obtain 105 g of purified ginkgolides.
  • 10) The mother liquor is concentrated under vacuum to eliminate the methanol, and the residue is then taken up with 2 l of water and heated at 90° C. under stirring for 30 minutes. The aqueous solution is separated, and the residue is taken up 3 more times with 2 l of water at 90° C., the aqueous solution being recovered every time.
  • 11) The combined aqueous solutions are concentrated to a volume of 0.4 l, and 0.1 l of MeOH is added; the resulting solution is heated at 50° C. under stirring for 30 minutes, then cooled to room temperature and left to crystallise for 3 days.
  • 12) The resulting solution is filtered and the solid is washed with 20% MeOH and dried under vacuum to obtain 102 g of purified bilobalide.
  • 13) The products obtained in points 5, 9 and 12 are mixed to give 2.6 kg of Ginkgo biloba extract similar to that obtained in example 1.
  • Example 5 Purification of a Purified Extract Containing Pesticides with a High Terpene Content
  • 1) 1 kg of Ginkgo biloba leaf extract containing 24% of ginkgo flavone glycosides, 12% of ginkgo terpenes, 2 ppm of ginkgolic acids and 315 ppb of chlorpyrifos and tricyclazole is suspended under stirring in 5 l of water.
  • 2) The suspension is extracted 12 times with 5 l of ethyl acetate at room temperature. The aqueous phase is then concentrated to a syrup-like consistency and dried under vacuum to obtain an intermediate enriched with ginkgo flavone glycosides and devoid of terpenes (810 g).
  • 3) The combined ethyl acetic phases are concentrated under vacuum to a syrup-like consistency, and the residue is taken up with 2 l of 50% aqueous ethanol.
  • The resulting solution is reflux heated under stirring for 1 hour, then cooled to room temperature and left to crystallise for 2 days.
  • 4) The solution is then filtered and the solid washed with 50% EtOH and dried under vacuum, to obtain 82 g of purified ginkgolides.
  • 5) The mother liquor is concentrated under vacuum to eliminate the ethanol, and the residue is then taken up with 2 l of water and heated at 90° C. under stirring for 15 minutes. The aqueous solution is separated, and the residue is taken up a second time with 2 l of water at 90° C., the aqueous solution being recovered.
  • 6) The aqueous solutions are combined and concentrated under vacuum to a syrup-like consistency; the residue is then taken up with 400 ml of 10% EtOH. The resulting solution is heated at 50° C. under stirring for 60 minutes, then cooled to room temperature and left to crystallise for 2 days.
  • 7) The solution is filtered and the solid is washed with 10% EtOH and dried under vacuum to obtain 70 g of purified bilobalide.
  • 8) 41 g of purified ginkgolides and 35 g of purified bilobalide are mixed with the product obtained in point 2 to give 885 g of Ginkgo biloba extract with the following characteristics: a. ginkgo flavone glycosides 27%; b. ginkgo terpenes 6.8%; c. ginkgolic acids 1.0 ppm; d. each pesticide<10 ppb.
  • The process described removes the pesticides and allows the terpene content of the Ginkgo biloba extracts to be controlled, adjusting it as required at the step when the purified intermediates are mixed. In practice, the 24/6 ratio (GFG/GT) considered ideal in the extracts often differs from the natural ratio encountered in the plants. For example, Chinese leaves often have a higher terpene content, and a ginkgo terpene titre reduction step is required to obtain conforming extracts.
  • The table below shows the pesticide contents of extracts obtained according to the procedures described above. Two tests were conducted for each example: the procedure disclosed in the patent was exactly followed in the first, and treatment of the terpene fraction was added in the second.
  • All the extracts were obtained from the same plant.
  • Example 1-Ref. Example 2-Ref.
    Indena patents Indena patents
    U.S. Pat. No. U.S. Pat. No. Example 3-Ref. Example 4-Ref.
    5,700,468, 5,700,468, Schwabe patent Nippon
    EP 0 3600 556 B1; EP 0 3600 556 B1; EP 0 431 535 B1; Green Wave patent
    example I example II example I J09110713
    Before After Before After Before After Before After
    pesticide pesticide pesticide pesticide pesticide pesticide Pesticide pesticide
    removal removal removal removal removal removal removal removal
    Tricyclazole 85 <10 55 <10 63 <10 212 <10
    (ppb)
    Acetamiprid 24 <10 16 <10 27 <10 92 <10
    (ppb)
    Imidacloprid 48 <10 37 <10 45 <10 175 <10
    (ppb)
    Phorate 33 <10 28 <10 26 <10 84 <10
    (ppb)

Claims (5)

1. Extracts obtainable according to a process for removing pesticides from Ginkgo biloba extracts, obtained by conventional methods, said process comprising:
a) subjecting said Ginkgo biloba extracts to liquid-liquid extraction to obtain a first fraction containing ginkgo terpenes and pesticides not removable with hexane, and a second fraction containing ginkgo flavone glycosides;
b) crystallizing the ginkgo terpenes from the first fraction obtained at step a) to give a ginkgolide intermediate with a ginkgolide content of not less than 50% w/w and a residual solution;
c) crystallizing the residual solution obtained in step b) to obtain a bilobalide intermediate with a bilobalide content of not less than 50% w/w;
d) mixing the second fraction obtained in step a) with the ginkgolide intermediate and the bilobalide intermediate obtained at steps b) and c) thereby removing said pesticides from said Ginkgo biloba extracts.
2. The extracts as claimed in claim 1, wherein the extraction of step a) is carried out with a water-immiscible solvent selected from esters, chlorinated hydrocarbons, mixtures of hydrocarbons and alcohols, ketones and mixtures of ketones and alcohols.
3. The extracts as claimed in claim 2 wherein the solvent is an ester having 2 to 8 carbon atoms.
4. The extracts as claimed in claim 1 wherein the crystallisation of ginkgo terpenes is carried out in mixtures of water and C1-C3 alcohols.
5. The extracts as claimed in claim 1 wherein the crystallisation from the terpene-rich fraction of step c) is carried out in water or in a mixture of water and C1-C3 alcohols.
US15/334,346 2009-04-06 2016-10-26 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process Abandoned US20170042952A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/334,346 US20170042952A1 (en) 2009-04-06 2016-10-26 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI2009A000548 2009-04-06
IT000548A ITMI20090548A1 (en) 2009-04-06 2009-04-06 PROCESS OF REMOVAL OF PESTICIDES FROM GINKGO BILOBA EXTRACTS AND EXTRACTS OBTAINED FROM SUCH PROCESS
PCT/EP2010/002046 WO2010115566A2 (en) 2009-04-06 2010-03-31 Process for removing pesticides from gingko biloba extracts, and extracts obtainable by said process
US201113258715A 2011-11-18 2011-11-18
US15/334,346 US20170042952A1 (en) 2009-04-06 2016-10-26 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US13/258,715 Continuation US20120100232A1 (en) 2009-04-06 2010-03-31 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process
PCT/EP2010/002046 Continuation WO2010115566A2 (en) 2009-04-06 2010-03-31 Process for removing pesticides from gingko biloba extracts, and extracts obtainable by said process

Publications (1)

Publication Number Publication Date
US20170042952A1 true US20170042952A1 (en) 2017-02-16

Family

ID=41786232

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/258,715 Active 2033-09-28 US9504270B2 (en) 2009-04-06 2010-03-31 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process
US13/258,715 Granted US20120100232A1 (en) 2009-04-06 2010-03-31 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process
US15/334,346 Abandoned US20170042952A1 (en) 2009-04-06 2016-10-26 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US13/258,715 Active 2033-09-28 US9504270B2 (en) 2009-04-06 2010-03-31 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process
US13/258,715 Granted US20120100232A1 (en) 2009-04-06 2010-03-31 Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process

Country Status (21)

Country Link
US (3) US9504270B2 (en)
EP (2) EP2427662B1 (en)
JP (1) JP5745499B2 (en)
KR (1) KR101350433B1 (en)
CN (1) CN102368911A (en)
AU (1) AU2010234008B2 (en)
BR (1) BRPI1016023B1 (en)
CA (1) CA2757925C (en)
CL (1) CL2011002474A1 (en)
DK (1) DK2427662T3 (en)
ES (1) ES2402235T3 (en)
HR (1) HRP20130151T1 (en)
IL (1) IL215546A (en)
IT (1) ITMI20090548A1 (en)
MX (1) MX2011010510A (en)
PL (1) PL2427662T3 (en)
PT (1) PT2427662E (en)
RU (2) RU2514673C2 (en)
SG (1) SG175065A1 (en)
SI (1) SI2427662T1 (en)
WO (1) WO2010115566A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8926644B2 (en) * 2009-07-30 2015-01-06 Becton, Dickinson And Company Lancing device having saddle-shaped tip
KR101722829B1 (en) 2015-02-16 2017-04-05 주식회사 한국인삼공사 Method of Removing Residual Agricultural Chemicals from Plant
CN107670218A (en) * 2017-08-24 2018-02-09 江苏金纳多生物科技有限公司 A kind of method of ultraviolet assisted photo-catalysis degraded ginkgo leaf Pesticide Residues
CN109762800B (en) * 2018-12-14 2022-04-08 南京农业大学 Acetamiprid amidase gene aceAB and coding protein and application thereof
CN114367076A (en) * 2021-11-26 2022-04-19 湖南科技学院 A kind of method for removing residual pesticide in ginkgo extract

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660832A (en) * 1994-07-14 1997-08-26 Emil Flachsmann Ag Process for the preparation of pesticide-poor concentrates of active components of plants

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4927323A (en) * 1972-07-04 1974-03-11
US4753929A (en) * 1986-03-12 1988-06-28 Daicel Chemical Industries, Ltd. Flavone glycoside
US5637302A (en) * 1988-09-20 1997-06-10 Indena Spa Extracts of Ginkgo biloba and their methods of preparation
GB8822004D0 (en) 1988-09-20 1988-10-19 Indena Spa New extracts of ginkgo biloba & their methods of preparation
DE3940091A1 (en) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co EXTRACT OF BLACKERS OF GINKGO BILOBA, METHOD FOR THE PRODUCTION THEREOF AND THE EXTRACT CONTAINING MEDICAMENT
DE3940094A1 (en) * 1989-12-04 1991-06-06 Montana Ltd ACTIVE CONCENTRATES AND NEW ACTIVE COMBINATIONS FROM BLACKERS OF GINKGO BILOBA, A METHOD FOR THE PRODUCTION THEREOF, AND THE ACTIVE CONCENTRATES THE DRUG COMBINATIONS CONTAINING DRUG COMPOUNDS
ATE212790T1 (en) * 1995-03-06 2002-02-15 Flachsmann Ag Emil METHOD FOR REMOVAL OF UNDESIRABLE LIPOPHILIC CONTAMINANTS AND/OR RESIDUE CONTAINED IN BEVERAGES OR VEGETABLE PREPARATIONS
JPH09110713A (en) 1995-10-13 1997-04-28 Nippon Green Ueebu Kk Glutathione-S-transferase activator, and pharmaceuticals and food and drink containing the same
JP4249388B2 (en) * 1997-11-25 2009-04-02 ファーマネックス,インコーポレイティド Preparation method of ginkgo biloba extract
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
US6132726A (en) * 1998-10-21 2000-10-17 Hauser, Inc. Process for removing impurities from natural product extracts
CN1322723A (en) * 2001-04-24 2001-11-21 哈尔滨市应用技术研究所 Method of extracting flavone and terpenes from gingko leaf with CO2 in subcritical state
US7763741B2 (en) * 2003-11-12 2010-07-27 The Trustees Of Columbia University In The City Of New York Separation of ginkgolides and bilobalide from G. biloba
KR100623164B1 (en) * 2004-07-22 2006-09-19 재단법인서울대학교산학협력재단 Method for purifying novel ginkgo biloba extract having neuroprotective effect and composition containing same
CN100391979C (en) * 2004-12-02 2008-06-04 华东师范大学 A kind of monomethoxypolyethylene glycol-insulin compound and its preparation method
WO2006117170A1 (en) * 2005-05-03 2006-11-09 Dr. Willmar Schwabe Gmbh & Co. Kg Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons
AU2006325214A1 (en) 2005-12-15 2007-06-21 Laboratoires Serono S.A. New chemokine antagonists
KR100723609B1 (en) * 2006-04-28 2007-06-04 주식회사 유유 Ginkgo biloba extract for the prevention or treatment of Alzheimer's dementia and Parkinson's disease, as well as extraction and purification method from ginkgo biloba
FR2926994B1 (en) * 2008-02-06 2010-08-27 Sod Conseils Rech Applic NEW PROCESS FOR THE PREPARATION OF GINKGO BILOBA EXTRACTS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660832A (en) * 1994-07-14 1997-08-26 Emil Flachsmann Ag Process for the preparation of pesticide-poor concentrates of active components of plants

Also Published As

Publication number Publication date
CN102368911A (en) 2012-03-07
MX2011010510A (en) 2011-11-29
KR20120004986A (en) 2012-01-13
DK2427662T3 (en) 2013-03-25
JP5745499B2 (en) 2015-07-08
RU2011140482A (en) 2013-05-20
SG175065A1 (en) 2011-11-28
ES2402235T3 (en) 2013-04-30
KR101350433B1 (en) 2014-01-14
WO2010115566A8 (en) 2010-12-23
IL215546A0 (en) 2011-12-29
PT2427662E (en) 2013-04-03
HRP20130151T1 (en) 2013-03-31
US20120100232A1 (en) 2012-04-26
CA2757925C (en) 2017-10-17
AU2010234008B2 (en) 2015-04-30
WO2010115566A2 (en) 2010-10-14
EP2554054A1 (en) 2013-02-06
CL2011002474A1 (en) 2012-03-23
WO2010115566A3 (en) 2011-02-10
AU2010234008A1 (en) 2011-11-03
ITMI20090548A1 (en) 2010-10-07
CA2757925A1 (en) 2010-10-14
JP2012522815A (en) 2012-09-27
RU2514673C2 (en) 2014-04-27
BRPI1016023B1 (en) 2019-06-18
BRPI1016023A8 (en) 2017-12-05
IL215546A (en) 2015-01-29
PL2427662T3 (en) 2013-06-28
EP2427662A2 (en) 2012-03-14
US9504270B2 (en) 2016-11-29
SI2427662T1 (en) 2013-04-30
RU2014106648A (en) 2015-08-27
BRPI1016023A2 (en) 2015-09-01
EP2427662B1 (en) 2013-01-09

Similar Documents

Publication Publication Date Title
US20170042952A1 (en) Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process
DE3940092C2 (en)
JP2800040B2 (en) New extract of ginkgo and its manufacturing method
CH686556A5 (en) Process for the preparation of pesticide-poor concentrates of active ingredient from plants.
DE19756848C2 (en) Extracts from Ginkgo biloba leaves with a reduced content of 4&#39;-O-methylpyridoxine and biflavones
US4956429A (en) Method of making a coca leaf flavor extract
AT502717A1 (en) PHARMACEUTICAL USE OF A COMPOUND
KR19990073622A (en) Manufacture method of drink for white stone extract contain
US20080306141A1 (en) Method of Extraction of Catechin Type-A Proanthocyanidins
US10293013B2 (en) Water soluble Psidium guajava leaf extract having standardized phytochemicals
WO2000013696A1 (en) Composition for improving mental capabilities in mammals
WO2017103831A1 (en) Bitterless bacopa monnieri extract composition for memory improvement and a method of synthesizing the same
KR20100045485A (en) Method of making distilled olive juice extracts
WO2007066926A1 (en) A mass production method of brazilein from caesalpinia sappan l
HK1162254A (en) Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process
DE2358434A1 (en) METHOD FOR PURIFYING VEGETABLE FLAVONE EXTRACTS
DE102009040381A1 (en) Process for the isolation of alkaloids from plants
CN106727745B (en) Method for preparing low-acid ginkgo leaf extract
DE2448278A1 (en) PROCESS FOR THE PRODUCTION OF LIQUID OR POWDERED COLD-SOLUBLE TEA CONCENTRATES
DE2327477B2 (en) Process for the production of plant or drug ingredient extracts for the production of spirits and the use of these extracts
JPS62246591A (en) Production of extraction of active ingredient in gymnema-sylvestre r-br
EP1757194A1 (en) Use of mixtures of polyphenols and physiologically active unsaturated fatty acids
CZ286430B6 (en) Isolation process of crystalline silybin and silymarin
PL151692B1 (en) A method for separating antocyans from whortleberry /vaccinium myrtillus/

Legal Events

Date Code Title Description
AS Assignment

Owner name: INDENA S.P.A., ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GIORI, ANDREA;MOMBELLI, GIACOMO;ARPINI, SABRINA;AND OTHERS;REEL/FRAME:040132/0108

Effective date: 20111109

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION